REFERENCES
- Guyer D R, Tiedeman J, Yannuzzi L A, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111: 350–6
- Hayasaka S, Fujii M, Yamamoto Y, Noda S, Kurome H, Sasaki M. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa. Br J Ophthalmol 1995; 79: 150–2
- Hayasaka S, Nagaki Y, Matsumoto M, Sato S. Interferon associated retinopathy. Br J Ophthalmol 1998; 82: 323–5
- Hejny C, Sternberg P, Lawson D H, Greiner K, Aaberg T M, Jr. Retinopathy associated with high-dose interferon alfa-2b therapy. Am J Ophthalmol 2001; 131: 782–7
- Kadayifcilar S, Boyacioglu S, Kart H, Gursoy M, Aydin P. Ocular complications with high-dose interferon alpha in chronic active hepatitis. Eye 1999; 13: 241–6, (Pt 2)
- Schulman J A, Liang C, Kooragayala L M, King J. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology 2003; 110: 437–42
- Cuthbertson F M, Davies M, McKibbin M. Is screening for interferon retinopathy in hepatitis C justified?. Br J Ophthalmol 2004; 88: 1518–20
- Purvin V A. Anterior ischemic optic neuropathy secondary to interferon alfa. Arch Ophthalmol 1995; 113: 1041–4
- Sugano S, Yanagimoto M, Suzuki T, et al. Retinal complications with elevated circulating plasma C5a associated with interferon-alpha therapy for chronic active hepatitis C. Am J Gastroenterol 1994; 89: 2054–6
- Okuse C, Yotsuyanagi H, Nagase Y, et al. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2006; 12: 3756–9
- Sommer S, Sablon J C, Zaoui M, Rozot P, Hosni A. Interferon beta-1b retinopathy during a treatment for multiple sclerosis. J Fr Ophtalmol 2001; 24: 509–12
- Mallada-Frechin J, Abellan-Miralles I, Alfaro-Beltra M L, et al. Retinopathy secondary to treatment with Interferon beta-1a in a patient with multiple sclerosis. Rev Neurol 2005; 40: 482–4
- Baron S, Tyring S K, Fleischmann W R, Jr., et al. The interferons. Mechanisms of action and clinical applications. JAMA 1991; 266: 1375–83
- Taniguchi T, Mantei N, Schwarzstein M, Nagata S, Muramatsu M, Weissmann C. Human leukocyte and fibroblast interferons are structurally related. Nature 1980; 285: 547–9
- Novick D, Cohen B, Rubinstein M. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 1994; 77: 391–400
- Neilley L K, Goodin D S, Goodkin D E, Hauser S L. Side effect profile of interferon beta-1b in MS: results of an open label trial. Neurology 1996; 46: 552–4